PYCR1
Pyrroline-5-carboxylate reductase 1, mitochondrial
Also known as: P5C, P5CR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P32322
- Gene
- PYCR1
- Ensembl
- ENSG00000183010
- Chromosome
- 17
- Canonical length
- 319 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homodecamer
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>P32322|PYCR1
1 MSVGFIGAGQ LAFALAKGFT AAGVLAAHKI MASSPDMDLA TVSALRKMGV KLTPHNKETV
61 QHSDVLFLAV KPHIIPFILD EIGADIEDRH IVVSCAAGVT ISSIEKKLSA FRPAPRVIRC
121 MTNTPVVVRE GATVYATGTH AQVEDGRLME QLLSSVGFCT EVEEDLIDAV TGLSGSGPAY
181 AFTALDALAD GGVKMGLPRR LAVRLGAQAL LGAAKMLLHS EQHPGQLKDN VSSPGGATIH
241 ALHVLESGGF RSLLINAVEA SCIRTRELQS MADQEQVSPA AIKKTILDKV KLDSPAGTAL
301 SPSGHTKLLP RSLAPAGKDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PYCR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 114 nTPM
- pancreas: 105 nTPM
- stomach: 40 nTPM
- prostate: 24 nTPM
- cervix: 23 nTPM
- colon: 22 nTPM
Single-cell type
- breast lactating cells: 229 nCPM
- extravillous trophoblasts: 111 nCPM
- gastric chief cells: 69 nCPM
- goblet cells: 66 nCPM
- salivary acinar cells: 61 nCPM
- pancreatic acinar cells: 56 nCPM
Immune cell
- memory B-cell: 4.3 nTPM
- plasmacytoid DC: 1.9 nTPM
- naive B-cell: 1.8 nTPM
- naive CD4 T-cell: 1.6 nTPM
- myeloid DC: 1.3 nTPM
- naive CD8 T-cell: 1.2 nTPM
Brain region
- medulla oblongata: 21 nTPM
- thalamus: 20 nTPM
- pons: 18 nTPM
- hypothalamus: 17 nTPM
- basal ganglia: 16 nTPM
- midbrain: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PYCR1.
Disease | AllUniProt
Conditions PYCR1 is implicated in, by any mechanism.
- Cutis laxa, autosomal recessive, 2B (ARCL2B) MIM:612940
- Cutis laxa, autosomal recessive, 3B (ARCL3B) MIM:614438
Disease | GeneticClinVar
47 pathogenic / likely-pathogenic of 379 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive cutis laxa type 2B
- PYCR1-related de Barsy syndrome
- Cutis laxa
- PYCR1-related disorder
- Wiedemann-Rautenstrauch-like progeroid syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to oxidative stress
- L-proline biosynthetic process
- negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
- regulation of mitochondrial membrane potential
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pyrroline-5-carboxylate reductase-like
- 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
- Pyrroline-5-carboxylate reductase, catalytic, N-terminal
- Pyrroline-5-carboxylate reductase, dimerisation domain
- NAD(P)-binding domain superfamily
- Pyrroline-5-carboxylate reductase-like conserved site
- NADP oxidoreductase coenzyme F420-dependent
- Pyrroline-5-carboxylate reductase dimerisation
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PYCR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PYCR1 as an antibody target. Whether an autoantibody or antibody against PYCR1 could matter depends on whether native PYCR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PYCR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PYCR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...